2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1 |
Follow NSTEMI - Non-ST Segment Elevation MI: new trials by email Literature Review of NSTEMI - Non-ST Segment Elevation MI trials Research Report on NSTEMI - Non-ST Segment Elevation MI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? 30-day DAPT, Guideline-directed therapy - Acute Coronary Syndrome, Myocardial Infarction | Phase 4 | Recruiting | St. Antonius Hospital | 2000 | 2023-01-11 | 2023-12-15 |
| Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI Evolocumab 140 MG/ML, Standard of care (SOC) - STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI | Phase 4 | Active not recruiting | Assistance Publique - Hôpitaux de Paris | 2166 | 2021-09-29 | 2026-04-13 |
| Implementing Precision Medicine Approaches to Guide Anti-platelet Selection CYP2C19 genotyping - Acute Coronary Syndrome (ACS), STEMI - ST Elevation Myocardial Infarction (MI) | Phase 4 | Unknown | University of Southern California | 200 | 2020-03-13 | 2021-09-28 |
| Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg Clopidogrel - Diabetes Mellitus, Type 2, NSTEMI - Non-ST Segment Elevation MI | Phase 4 | Completed | Laboratoires Teriak | 167 | 2017-12-07 | 2019-12-23 |
| Early Management Strategies of Acute Heart Failure for Patients With NSTEMI Regular management+Levosimendan - Early Management, Acute Heart Failure | Phase 4 | Unknown | Qilu Hospital of Shandong University | 470 | 2017-07-01 | 2021-07-19 |
| Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction Clopidogrel, Ticagrelor - Acute Coronary Syndrome, STEMI | Phase 4 | Completed | University of Zagreb | 120 | 2015-12-01 | 2020-04-30 |
Non-ST Elevated Myocardial Infarction (6) · ST Elevation Myocardial Infarction (4) · Acute Coronary Syndrome (3) · Angina, Unstable (1) · Atrial Fibrillation (1) · Atrial Flutter (1) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1) · Embolism (1) · Hemorrhage (1) · Myocardial Infarction (1) · Stroke (1) · Thrombosis (1)
Cardiovascular Diseases (6) · Heart Diseases (6) · Infarction (6) · Ischemia (6) · Myocardial Ischemia (6) · Necrosis (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Vascular Diseases (6) · Myocardial Infarction (5) · Angina Pectoris (1) · Arrhythmias, Cardiac (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Brain Diseases (1)
Clopidogrel (2) · 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1) · Standard of Care (1) · Ticagrelor (1) · evolocumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Laboratoires Teriak (1) · Qilu Hospital of Shandong University (1) · St. Antonius Hospital (1) · University of Southern California (1) · University of Zagreb (1)
Belgium (1) · China (1) · Croatia (1) · France (1) · Netherlands (1) · Tunisia (1) · United States (1)